Flow cytometry is a powerful technology that is widely used in both clinical and basic research due to its ability to perform multiparametric analysis of cells. However, traditional flow cytometry platforms have slow sampling speeds and require large sample volumes. Increased sampling speed and reduced sample volumes are therefore critical to enable flow cytometry for high throughput screening applications.
This special issue comprises of a collection of research papers, application notes, and technical notes from leading pharmaceutical and academic organizations like AstraZeneca, Takeda, Novartis, Bristol Myers and Squibb, Kite Pharma, Finnish Institute of Molecular Medicine and many more that reflect recent advances in this field, provide new insights and perspectives for the design of high throughput flow cytometry platforms and highlight its broad range of applications in drug discovery.
Complete the form below to access the complete issue